India intensifies drug regulator surveillance of weight loss drugs amid unauthorized sales concerns.

India's drug regulator has intensified surveillance of GLP-1 weight loss drugs amid concerns over unauthorized sales and misuse. The government conducted inspections at 49 entities, including online pharmacies and clinics, to crack down on improper prescriptions and misleading marketing. Authorities emphasize these drugs require medical supervision and carry health risks if misused.